Table 3 ROCKII S1366 phosphorylation nuclear expressions in invasive breast cancers
From: Immunohistochemical evaluation of ROCK activation in invasive breast cancer
| Â | Number | Mean % (standard deviation) | P a |
|---|---|---|---|
Age (years) | |||
 <50 | 90 | 13.6 (25.8) | 0.706 |
 ≥ 50 | 129 | 14.9 (26.2) | |
Grade | Â | Â | Â |
 1 | 13 | 2.7 (6.0) | ] 0.220 ] 0.637 |
 2 | 136 | 13.9 (25.5) | |
 3 | 70 | 17.5 (28.6) | |
Stage | |||
 I/II | 147 | 9.8 (21.5) | 0.003 |
 III/IV | 72 | 23.7 (31.5) | |
ER | Â | Â | Â |
 Negative | 131 | 23.3 (30.6) | 0.002 |
 Positive | 81 | 9.0 (20.8) | |
PR | |||
 Negative | 112 | 20.1 (30) | 0.017 |
 Positive | 99 | 8.2 (18.6) | |
HER2 | |||
 Negative | 154 | 11.3 (23) | 0.017 |
 Positive | 57 | 22.8 (31.4) | |
Ki67 | |||
 < 20 % | 34 | 5.9 (13.4) | 0.044 |
 ≥ 20 % | 36 | 17.8 (25.1) | |